glp 1 agonist binge eating disorder GLP-1 receptor agonists: A novel pharmacotherapy for (Binge eating and bulimia nervosa)? A systematic review GLP‐1 Receptor Agonist Medications for
Description
10.4314/ahs.v19i3.35 36
Berglund LM, Lyssenko V, Ladenvall C, Kotova O, Edsfeldt A, Pilgaard K, et al
Zatorski H, Saaga M, Fichna J
Compound-Specific Oncologic Effects As highlighted in this meta-analysis, no conclusive association between the use of GLP-1 RAs and an increase in gastrointestinal cancers has been established
doi: 10.1016/j.cmet.2018.03.001
